Quantitative HPLC determination of S-carboxymethyl-L-cysteine in pharmaceutical dosage form
Bovis, G.; Chiesi, P.
Bollettino Chimico Farmaceutico 119(3): 172-176
1980
ISSN/ISBN: 0006-6648 PMID: 7459039 Document Number: 163706
Document emailed within 1 workday
Related Documents
Caccialanza, G.; Gandini, C. 1981: Simultaneous HPLC analysis of S-carboxymethyl-L-cysteine and theophylline in pharmaceutical form Il Farmaco; Edizione Pratica 36(8): 396-402De Smet, M.; Dryon, L.; Massart, D.L. 1985: Separation and determination of sulphonamides in a pharmaceutical dosage form by HPLC using optimisation procedures Journal de Pharmacie de Belgique 40(2): 100-106
Dudkiewicz-Wilczyńska, J.; Snycerski, A.; Tautt, J. 2000: HPLC method for the determination of oxytocin in pharmaceutical dosage form and comparison with biological method Acta Poloniae Pharmaceutica 57(6): 403-406
Nikolić, K.I.; Velasević, K.R.; Ruasse, M.F. 1988: Coulometric determination of S-carboxymethyl-L-cysteine Journal de Pharmacie de Belgique 43(1): 26-28
Helfand, W.H.; Pejouan, B.L. 1983: A new dosage form of indomethacin. Pharmaceutical profile of an oral form with osmotically controlled release Annales Pharmaceutiques Francaises 41(5): 401-408
Amin, A.S. 2001: Pyrocatechol violet in pharmaceutical analysis. Part I. A spectrophotometric method for the determination of some beta-lactam antibiotics in pure and in pharmaceutical dosage forms Farmaco 56(3): 211-218
Usman, S.; Akram, M.; Aziz, A.; Ramesh, V.; Sarheed, O.A. 2014: Development and validation of HPLC analytical method for nepafenac in ophthalmic dosage form (suspension) Pakistan Journal of Pharmaceutical Sciences 27(Special Issue 5): 1541-1546
Venkateswarlu, K.; Rangareddy, A.; Narasimhaiah, K.; Sharma, H.; Bandi, N.M.R. 2017: A validated stability indicating RP-HPLC method for estimation of Armodafinil in pharmaceutical dosage forms and characterization of its base hydrolytic product Pakistan Journal of Pharmaceutical Sciences 30(1): 23-28
Den Brok, M.W.J.; Nuijen, B.; Kettenes-Van Den Bosch, J.J.; Van Steenbergen, M.J.; Buluran, J.N.; Harvey, M.D.; Grieshaber, C.K.; Beijnen, J.H. 2005: Pharmaceutical development of a parenteral lyophilised dosage form for the novel anticancer agent C1311 PDA Journal of Pharmaceutical Science and Technology 59(5): 285-297
Fiori, A.; Costa, M.; Barboni, E. 1972: Oxidation of S-carboxymethyl-L-cysteine by glutamate dehydrogenase Physiological Chemistry and Physics 4(5): 457-466
Sultana, N.; Arayne, M.S.; Hussain, F.; Fatima, A. 2006: Degradation studies of azithromycin and its spectrophotometric determination in pharmaceutical dosage forms Pakistan Journal of Pharmaceutical Sciences 19(2): 98-103
Joneidi, M.; Koleva, M.; Budevsky, O. 1975: Quantitative determination of drugs by means of densitometry of thin-layer chromatograms. Part 5: Determination of the Vitamins B1, B2, B6 and B12 in mixture and in pharmaceutical preparations Die Pharmazie 30(7): 453-455
Barden, A.T.; Piccoli, B.L.; Volpato, N.M.; Schapoval, E.E.S.; Steppe, M. 2014: Capillary zone electrophoresis for determination of vildagliptin (a DPP-4 inhibitor) in pharmaceutical formulation and comparative study with HPLC Die Pharmazie 69(2): 86-91
Patel, S.K.; Patel, N.J. 2010: Simultaneous determination of imipramine hydrochloride and chlordiazepoxide in pharmaceutical preparations by spectrophotometric, RP-HPLC, and HPTLC methods Journal - Association of Official Analytical Chemists 93(3): 904-910
Mohamed, M.E.; Tawakkol, M.S.; Aboul-Enein, H.Y. 1983: Spectrofluorometric determination of pindolol and its dosage form Journal - Association of Official Analytical Chemists 66(2): 273-275
Antoniou, C.G.; Markopoulou, C.K.; Kouskoura, M.G.; Koundourellis, J.E. 2011: Study and development of reversed-phase HPLC systems for the determination of 2-imidazolines in the presence of preservatives in pharmaceutical preparations Journal - Association of Official Analytical Chemists 94(3): 703-712
Rodríguez, J.C.; Barciela, J.; García, S.; Herrero, C.; Peña, R.M. 2005: Optimization of two flow-injection spectrophotometric methods for the determination of indapamide in pharmaceutical dosage forms Journal - Association of Official Analytical Chemists 88(4): 1148-1154
Facchini, G.; Filippi, G.; Cantoni, R.; Nannetti, M. 1987: Quantitative determination of feprazone in the presence of possible degradation by HPLC Bollettino Chimico Farmaceutico 126(6): 244-245
Bellotti, L.; Frigo, G. 1983: Quantitative simultaneous determination with HPLC of clofibrate and pyridinolcarbamate Bollettino Chimico Farmaceutico 122(3): 143-148
Iguchi, Y.; Tokuda, H.; Kishioka, S.; Ozaki, M.; Tamura, S.; Yamamoto, H. 1984: A specific and quantitative determination of rat beta-endorphin. Combination of HPLC and RIA Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 84(4): 385-393